Hippocampal atrophy rates in Alzheimer disease
Wouter J.P. Henneman(UK Dementia Research Institute), Frederik Barkhof(Netherlands Institute for Neuroscience), Ingrid C. Sluimer(Amsterdam UMC Location Vrije Universiteit Amsterdam), Philip Scheltens(Inserm), Josephine Barnes(UK Dementia Research Institute), Jasper D. Sluimer(Amsterdam UMC Location Vrije Universiteit Amsterdam), Hugo Vrenken(Amsterdam Neuroscience), Wiesje M. van der Flier(Amsterdam Neuroscience), Nick C. Fox(NIHR Queen Square Dementia Biomedical Research Unit)
Cited by 391
Related Papers
Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria
|The Lancet Neurology|2017|8k
Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration
|The Lancet Neurology|2013|5.4k
Consistent resting-state networks across healthy subjects
|Proceedings of the National Academy of Sciences|2006|4.4k
Clinical and Biomarker Changes in Dominantly Inherited Alzheimer's Disease
|New England Journal of Medicine|2012|3.8k
Defining the clinical course of multiple sclerosis
|Neurology|2014|3.1k